Elanco Animal Health Incorporated (ELAN) — Analyst outlook / Analyst consensus target is. Based on 20 analyst ratings, the consensus is bullish — 14 Buy, 4 Hold, 2 Sell.
The consensus price target is $27.88 (low: $22.00, high: $30.00), representing an upside of 15.6% from the current price $24.11.
Analysts estimate Earnings Per Share (EPS) of $0.91 and revenue of $4.42B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.68 vs est $0.91 (missed -25.5%). 2025: actual $-0.47 vs est $0.93 (missed -150.4%). Analyst accuracy: 0%.
ELAN Stock — 12-Month Price Forecast
$27.88
▲ +15.64% Upside
Average Price Target
Based on 20 Wall Street analysts offering 12-month price targets for Elanco Animal Health Incorporated, the average price target is $27.88, with a high forecast of $30.00, and a low forecast of $22.00.
The average price target represents a +15.64% change from the last price of $24.11.
Highest Price Target
$30.00
Average Price Target
$27.88
Lowest Price Target
$22.00
ELAN Analyst Ratings
Buy
Based on 20 analysts giving stock ratings to Elanco Animal Health Incorporated in the past 3 months
EPS Estimates — ELAN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.68
vs Est $0.91
▼ 34.3% off
2025
Actual –$0.47
vs Est $0.93
▼ 298.5% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
Revenue Estimates — ELAN
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $4.439B
vs Est $4.422B
▲ 0.4% off
2025
Actual $4.715B
vs Est $4.663B
▲ 1.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
